The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Cancer stem cell (CSC) resistance drivers
Abstract
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to conventional therapies than other cells within a tumor. CSC resistance can be induced secondary to radio- and chemotherapy, or even after chemotherapy secession. A combination of both intrinsic and extrinsic factors is contributed to CSC-mediated therapy resistance. CSCs represent protective autophagy and efficient cell cycling, along with highly qualified epithelial-mesenchymal transition (EMT) regulators, reactive oxygen species (ROS) scavengers, drug transporters, and anti-apoptotic and DNA repairing systems. In addition, CSCs develop cross-talking and share some characteristics with other cells within the tumor microenvironment (TME) being more intense in higher stage tumors, and thereby sophisticating tumor-targeted therapies. TME, in fact, is a nest for aggravating resistance mechanisms in CSCs. TME is exposed constantly to the nutritional, metabolic and oxygen deprivation; these conditions promote CSC adaptation. This review is aimed to discuss main (intrinsic and extrinsic) mechanisms of CSC resistance and suggest some strategies to revoke this important promoter of therapy failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Z., Sun, H., Provazník, J., Hackert, T., & Zöller, M. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1129-8 · Cited by 64
RetractedA human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Frisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722
Metabolic Reprogramming: the Emerging Concept and Associated Therapeutic Strategies
Yoshida, G. J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0221-y · Cited by 716
Bourboulia, D., & Stetler-Stevenson, W. G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.002 · Cited by 710
Lee, K.-M., Giltnane, J. M., Balko, J. M., Schwarz, L. J., Guerrero-Zotano, A. L., Hutchinson, K. E., Nixon, M. J., Estrada, M. V., Sánchez, V., Sanders, M. E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.009 · Cited by 650
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Landsberg, J., Kohlmeyer, J., Renn, M., Bald, T., Rogava, M., Cron, M., Fatho, M., Lennerz, V., Wölfel, T., Hölzel, M., et al. (2012) · Nature · doi:10.1038/nature11538 · Cited by 632
Chemotherapy resistance of glioblastoma stem cells
Eramo, A., Ricci-Vitiani, L., Zeuner, A., Pallini, R., Lotti, F., Sette, G., Pilozzi, E., Larocca, L. M., Peschle, C., & De Maria, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401872 · Cited by 623
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C., & Kuperwasser, C. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.011 · Cited by 598
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
Dirkse, A., Golebiewska, A., Buder, T., Nazarov, P. V., Muller, A., Poovathingal, S., Brons, N. H. C., Leite, S., Sauvageot, N., Sarkisjan, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09853-z · Cited by 529
Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479
Weng, Y.-S., Tseng, H.-Y., Chen, Y.-A., Shen, P.-C., Al Haq, A. T., Chen, L.-M., Tung, Y.-C., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 444
Bourguignon, L. Y. W., Peyrollier, K., Xia, W., & Gilad, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800109200 · Cited by 442
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
Gkretsi, V., & Stylianopoulos, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00145 · Cited by 390
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Luo, M., Shang, L., Brooks, M. D., Jiagge, E., Zhu, Y., Buschhaus, J. M., Conley, S., Fath, M. A., Davis, A., Gheordunescu, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.006 · Cited by 358
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
Mueller, M., Hermann, P. C., Witthauer, J., Rubio–Viqueira, B., Leicht, S. F., Huber, S., Ellwart, J. W., Mustafa, M., Bartenstein, P., D'Haese, J. G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.053 · Cited by 348
Pleiotropic Roles for ZEB1 in Cancer
Caramel, J., Ligier, M., & Puisieux, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2476 · Cited by 344
Role of integrated cancer nanomedicine in overcoming drug resistance
Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343
Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells
Cannito, S., Novo, E., Compagnone, A., Valfrè di Bonzo, L., Busletta, C., Zamara, E., Paternostro, C., Povero, D., Bandino, A., Bozzo, F., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn216 · Cited by 309
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
Kumar, S. M., Liu, S., Lu, H., Zhang, H., Zhang, P. J., Gimotty, P. A., Guerra, M., Guo, W., & Xu, X. (2012) · Oncogene · doi:10.1038/onc.2011.656 · Cited by 308
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Bocci, F., Gearhart-Serna, L., Boareto, M., Ribeiro, M., Ben-Jacob, E., Devi, G. R., Levine, H., Onuchic, J. N., & Jolly, M. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815345116 · Cited by 299
Bourguignon, L. Y. W., Wong, G., Earle, C., & Chen, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308528 · Cited by 293
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
Wang, D., Fu, L., Sun, H., Guo, L., & DuBois, R. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.064 · Cited by 292
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Colwell, N., Larion, M., Giles, A. J., Seldomridge, A. N., Sizdahkhani, S., Gilbert, M. R., & Park, D. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now258 · Cited by 284
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Joseph, J. P., Harishankar, M. K., Pillai, A. A., & Devi, A. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.004 · Cited by 282
Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277
Lu, H., Samanta, D., Xiang, L., Zhang, H., Hu, H., Chen, I., Bullen, J. W., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513433112 · Cited by 269
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2545 · Cited by 268
Zhao, P., Wang, Y., Kang, X., Wu, A., Yin, W., Tang, Y., Wang, J., Zhang, M., Duan, Y., & Huang, Y. (2018) · Chemical Science · doi:10.1039/c7sc04853j · Cited by 248
Shin, V. Y., Chen, J., Cheuk, I. W. Y., Siu, M.-T., Ho, C.-W., Wang, X., Jin, H., & Kwong, A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1513-5 · Cited by 248
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231
Katsuno, Y., Meyer, D. S., Zhang, Z., Shokat, K. M., Akhurst, R. J., Miyazono, K., & Derynck, R. (2019) · Science Signaling · doi:10.1126/scisignal.aau8544 · Cited by 220
Chen, X., Lingala, S., Khoobyari, S., Nolta, J., Zern, M. A., & Wu, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.043 · Cited by 211
Rausch, V., Liu, L., Kallifatidis, G., Baumann, B., Mattern, J., Gladkich, J., Wirth, T., Schemmer, P., Büchler, M. W., Zöller, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0066 · Cited by 209
Hu, Y.-B., Yan, C., Mu, L., Mi, Y. –., Zhao, H., Hu, H., Li, X.-L., Tao, D.-D., Wu, Y.-Q., Gong, J.-P., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0557-9 · Cited by 200
Brain tumor stem cells: Molecular characteristics and their impact on therapy
Schonberg, D. L., Lubelski, D., Miller, T. E., & Rich, J. N. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.004 · Cited by 198
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
Ubil, E., Caskey, L., Holtzhausen, A., Hunter, D., Story, C., & Earp, H. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97354 · Cited by 195
Mazor, G., Levin, L., Picard, D., Ahmadov, U., Carén, H., Borkhardt, A., Reifenberger, G., Leprivier, G., Remke, M., & Rotblat, B. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1477-5 · Cited by 174
Lenos, K. J., Miedema, D. M., Lodestijn, S. C., Nijman, L. E., van den Bosch, T., Romero Ros, X., Lourenço, F. C., Lecca, M. C., van der Heijden, M., van Neerven, S. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0179-z · Cited by 168
A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma
Lytle, N. K., Ferguson, L. P., Rajbhandari, N., Gilroy, K., Fox, R. G., Deshpande, A., Schürch, C. M., Hamilton, M., Robertson, N., Lin, W., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.010 · Cited by 162
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 160
Dietary polyphenol quercetin targets pancreatic cancer stem cells
Herr (2010) · International Journal of Oncology · doi:10.3892/ijo_00000704 · Cited by 158
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Melzer, C., von der Ohe, J., Lehnert, H., Ungefroren, H., & Hass, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0595-x · Cited by 158
Brown, J. A., Yonekubo, Y., Hanson, N., Sastre-Perona, A., Basin, A., Rytlewski, J. A., Dolgalev, I., Meehan, S., Tsirigos, A., Beronja, S., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.001 · Cited by 158
Appari, M., Babu, K. R., Kaczorowski, A., Groß, W., & Herr, I. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2539 · Cited by 157
A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells
Chefetz, I., Grimley, E. C., Yang, K. Y., Hong, L., Vinogradova, E. V., Suciu, R. M., Kovalenko, I., Karnak, D. M., Morgan, C. A., Chtcherbinine, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.032 · Cited by 155
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Shi, Y., Guryanova, O. A., Zhou, W., Liu, C., Huang, Z., Fang, X., Wang, X., Chen, C., Wu, Q., He, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6816 · Cited by 154
ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Wilson, B. J., Saab, K. R., Ma, J., Schatton, T., Pütz, P., Zhan, Q., Murphy, G. F., Gasser, M., Waaga-Gasser, A. M., Frank, N. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0582 · Cited by 151
The network of epithelial–mesenchymal transition: potential new targets for tumor resistance
Nantajit, D., Lin, D., & Li, J. J. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1840-y · Cited by 150
Li, N., Babaei‐Jadidi, R., Lorenzi, F., Spencer‐Dene, B., Clarke, P. A., Domingo, E., Tulchinsky, E. M., Vries, R. G. J., Kerr, D. J., Pan, Y., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0125-3 · Cited by 150
Zhuang, J., Shen, L., Yang, L., Huang, X., Lu, Q., Cui, Y., Zheng, X. E., Zhao, X., Zhang, D., Huang, R., et al. (2017) · Theranostics · doi:10.7150/thno.19542 · Cited by 144
Microenvironment-derived factors driving metastatic plasticity in melanoma
Kim, I. S., Heilmann, S., Kansler, E. R., Zhang, Y., Zimmer, M. A., Ratnakumar, K., Bowman, R. L., Simon-Vermot, T., Fennell, M., Garippa, R. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14343 · Cited by 142
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140
Gujar, A. D., Le, S. B., Mao, D. D., Dadey, D. Y. A., Turski, A., Sasaki, Y., Aum, D. J., Luo, J. R., Dahiya, S. M., Yuan, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610921114 · Cited by 139
Biddle, A., Gammon, L., Liang, K. X., Costea, D. E., & Mackenzie, I. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.007 · Cited by 137
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Zhang, D., Tang, D. G., & Rycaj, K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.001 · Cited by 137
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
Baquero, P., Dawson, A., Mukhopadhyay, A., Kuntz, E. M., Mitchell, R., Olivares, O., Ianniciello, A., Scott, M. T., Dunn, K. M., Nicastri, M. C., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0252-4 · Cited by 133
Wu, J., Zhu, P., Lu, T., Du, Y., Wang, Y., He, L., Ye, B., Liu, B., Yang, L., Wang, J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.015 · Cited by 132
Justilien, V., & Fields, A. P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0507 · Cited by 131
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
Talukdar, S., Pradhan, A. K., Bhoopathi, P., Shen, X., August, L. A., Windle, J. J., Sarkar, D., Furnari, F. B., Cavenee, W. K., Das, S. K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721650115 · Cited by 131
Qin, J., Liu, Y., Lu, Y., Liu, M., Li, M., Li, J., & Wu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09244-8 · Cited by 127
Dauer, P., Sharma, N., Gupta, V. K., Durden, B. C., Hadad, R., Banerjee, S., Dudeja, V., Saluja, A. K., & Banerjee, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1408-5 · Cited by 124
Park, H.-K., Hong, J.-H., Oh, Y. T., Kim, S. S., Yin, J., Lee, A., Chae, Y. C., Kim, J. H., Park, S., Park, C.-K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2558 · Cited by 122
Tejero, R., Huang, Y., Katsyv, I., Kluge, M., Lin, J., Tomé-García, J., Daviaud, N., Wang, Y., Zhang, B., Tsankova, N. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.064 · Cited by 122
Epithelial-Mesenchymal Transition Directs Stem Cell Polarity via Regulation of Mitofusin
Wu, M., Chen, Y., Kim, J.-H., Chang, C.-C., Gampala, S., Zhang, Y., Wang, Y., Chang, C., Yang, J.-Y., & Chang, C.-J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.004 · Cited by 120
Saha, S., Mukherjee, S., Khan, P., Kajal, K., Mazumdar, M., Manna, A., Mukherjee, S., De, S., Jana, D., Sarkar, D. K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1360 · Cited by 116
Wang, P., Wan, W., Xiong, S., Feng, H., & Wu, N. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.105 · Cited by 108
Jia, D., Li, L., Andrew, S., Allan, D., Li, X., Lee, J., Ji, G., Yao, Z., Gadde, S., Figeys, D., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.319 · Cited by 105
Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells
Chou, M., Hu, F., Yu, C., et al. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.10.002 · Cited by 105
Thakur, B. L., & Ray, P. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0636-8 · Cited by 105
Chen, C., Bai, L., Cao, F., Wang, S., He, H., Song, M., Chen, H., Liu, Y., Guo, J., Si, Q., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0735-4 · Cited by 104
The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
Alipoor, S. D., Mortaz, E., Varahram, M., Movassaghi, M., Kraneveld, A. D., Garssen, J., & Adcock, I. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00819 · Cited by 103
Zhang, M. F., Mathur, A., Zhang, Y., Xi, S., Atay, S. M., Hong, J. A., Datrice, N., Upham, T. C., Kemp, C. D., Ripley, R. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3983 · Cited by 101
Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance
Brown, Y., Hua, S., & Tanwar, P. S. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.002 · Cited by 100
Hu, Y., Guo, R., Wei, J., Zhou, Y., Ji, W., Liu, J., Zhi, X., & Zhang, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.363 · Cited by 98
Zhang, Z., Han, H., Rong, Y., Zhu, K., Zhu, Z., Tang, Z., Xiong, C., & Tao, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0972-3 · Cited by 97
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance
Najafi, M., Mortezaee, K., & Ahadi, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.076 · Cited by 97
Self-citationEmerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer
Abalkhail, K. A., & Kukuruzinska, M. A. (2018) · Journal of Dental Research · doi:10.1177/0022034518771923 · Cited by 94
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells
Marhold, M., Tomasich, E., El‐Gazzar, A., Heller, G., Spittler, A., Horvat, R., Krainer, M., & Horak, P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0153-t · Cited by 93
Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer
Srivastava, A. K., Banerjee, A. T., Cui, T., Han, C., Cai, S., Liu, L., Wu, D., Cui, R., Li, Z., Zhang, X., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3668 · Cited by 90
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Hou, Z.-J., Luo, X., Zhang, W., Peng, F., Cui, B., Wu, S.-J., Zheng, F.-M., Xu, J., Xu, L.-Z., Long, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3436 · Cited by 89
Li, H., Xu, F., Li, S., Zhong, A., Meng, X., & Lai, M. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129481 · Cited by 89
Yu, Q., Xue, Y., Liu, J., Xi, Z., Li, Z., & Liu, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00130 · Cited by 89
Characterization of stem cell–like cancer cells in immune-competent mice
Krüger, J. A., Kaplan, C. D., Luo, Y., Zhou, H., Markowitz, D., Xiang, R., & Reisfeld, R. A. (2006) · Blood · doi:10.1182/blood-2006-05-024687 · Cited by 88
Koh, S. Y., Moon, J. Y., Unno, T., & Cho, S. K. (2019) · Nutrients · doi:10.3390/nu11030624 · Cited by 88
Rhost, S., Hughes, É., Harrison, H., Rafnsdóttir, S., Jacobsson, H., Gregersson, P., Magnusson, Y., Fitzpatrick, P., Andersson, D., Berger, K., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1060-5 · Cited by 85
Yang, Z., Guo, F., Albers, A. E., Sehouli, J., & Kaufmann, A. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108727 · Cited by 85
Ouyang, S., Zhou, X., Chen, Q., Wang, M., Zheng, X., & Xie, M. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0784-3 · Cited by 84
Fekir, K., Dubois‐Pot‐Schneider, H., Désert, R., Daniel, Y., Glaise, D., Rauch, C., Morel, F., Fromenty, B., Musso, O. C., Cabillic, F., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2110 · Cited by 82
Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer
Wang, D., Plukker, J. T. M., & Coppes, R. P. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.010 · Cited by 81
miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
Wang, X., Meng, Q., Qiao, W., Ma, R., Ju, W., Hu, J., Lu, H., Cui, J., Jin, Z. H., Zhao, Y., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1072-1 · Cited by 81
Wang, L., Huang, X., Zheng, X., Wang, X., Li, S., Zhang, L., Yang, Z., & Xia, Z. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5855 · Cited by 80
Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer
Niu, D.-G., Peng, F., Zhang, W., Guan, Z., Zhao, H.-D., Li, J.-L., Wang, K.-L., Li, T., Zhang, Y., Zheng, F.-M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2894 · Cited by 79
Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling
Yu, L., Fan, Z., Fang, S., Yang, J., Gao, T., Simões, B. M., Eyre, R., Guo, W., & Clarke, R. B. (2016) · Oncotarget · doi:10.18632/oncotarget.8849 · Cited by 76
Kim, E. H., Na, H., Kim, D., Park, S., Kim, H., Song, N., & Surh, Y. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm299 · Cited by 75
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Balamurugan, K., Mendoza-Villanueva, D., Sharan, S., Summers, G. H., Dobrolecki, L. E., Lewis, M. T., & Sterneck, E. (2018) · Oncogene · doi:10.1038/s41388-018-0516-5 · Cited by 74
Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells
Taylor, W. R., Fedorka, S. R., Gad, I., Shah, R. V., Alqahtani, H. D., Koranne, R., Kuganesan, N., Dlamini, S., Rogers, T., Al-Hamashi, A. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42251-5 · Cited by 73
D’Andrea, F. P., Safwat, A., Kassem, M. S., Gautier, L., Overgaard, J., & Horsman, M. R. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.086 · Cited by 71
Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness
Hou, P., Li, Y.-H., Lin, S., Lin, S.-C., Lee, J., Lin, B.-W., Liou, J., Chang, J., Kuo, C., Liu, Y.-M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2990 · Cited by 71
Fan, C., Chen, T., Shang, Y.-N., Gu, Y.-Z., Zhang, S. L., Lu, R., OuYang, S.-R., Zhou, X., Li, Y., Wt, M., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.337 · Cited by 69
Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma
Zhao, M., Zhang, Y., Zhang, H., Wang, S., Zhang, M., Chen, X., Wang, H., Zeng, G., Chen, X., Liu, G., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.11.017 · Cited by 69
Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo
Wang, L., Long, L., Wang, W., & Liang, Z. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.11.001 · Cited by 68
Ojha, R., Singh, S. K., & Bhattacharyya, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.021 · Cited by 65
Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways
Kahlert, U. D., Mooney, S. M., Natsumeda, M., Steiger, H., & Maciaczyk, J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30259 · Cited by 64
Yeh, D., Huang, L.-R., Chen, Y., Huang, C. F., & Chuang, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/4368101 · Cited by 64
Ling, X., Wu, W., Fan, C., Xu, C., Liao, J., Rich, L. J., Huang, R.-Y., Repasky, E. A., Wang, X., & Li, F. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0899-8 · Cited by 64
Eckert, F., Zwirner, K., Boeke, S., Thorwarth, D., Zips, D., & Huber, S. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00407 · Cited by 62
Chikamatsu, K., Ishii, H., Murata, T., Sakakura, K., Shino, M., Toyoda, M., Takahashi, K., & Masuyama, K. (2013) · Cancer Science · doi:10.1111/cas.12271 · Cited by 61
Yadav, P., & Shankar, B. S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.055 · Cited by 61
Hypoxia After Liver Surgery Imposes an Aggressive Cancer Stem Cell Phenotype on Residual Tumor Cells
Govaert, K. M., Emmink, B. L., Nijkamp, M. W., Cheung, Z. J., Steller, E. J. A., Fátrai, S., de Bruijn, M. T., Kranenburg, O., & Rinkes, I. H. M. B. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e318295c160 · Cited by 60
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
Zhang, X., Milito, A. D., Olofsson, A. M., Gullbo, J., D’Arcy, P., & Linder, S. T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126020 · Cited by 59
Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145
Zhang, W. (2012) · Oncology Reports · doi:10.3892/or.2012.1701 · Cited by 56
Karandish, F., Froberg, J., Borowicz, P. P. P., Wilkinson, J. C., Choi, Y., & Mallik, S. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.12.036 · Cited by 52
KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
Liu, X., Zhang, S., McGeary, M. K., Krykbaeva, I., Lai, L., Jansen, D. J., Kales, S. C., Simeonov, A. M., Hall, M. D., Kelly, D. P., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0395 · Cited by 52
Zhu, Y., Tang, H., Zhang, L., Gong, L., Wu, G., Ni, J., & Tang, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s183328 · Cited by 50
Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells
Anuja, K., Chowdhury, A. R., Saha, A., Roy, S., Rath, A. K., Kar, M., & Banerjee, B. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1580401 · Cited by 49
Mondal, S., Bhattacharya, K., & Mandal, C. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0126-6 · Cited by 48
Metabolic reprogramming of the tumor microenvironment by p62 and its partners
Reina‐Campos, M., Shelton, P. M., Díaz-Meco, M. T., & Moscat, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.010 · Cited by 47
Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia
Dhawan, A., Tonekaboni, S. A. M., Taube, J. H., Hu, S. C., Sphyris, N., Mani, S. A., & Kohandel, M. (2016) · Scientific Reports · doi:10.1038/srep18074 · Cited by 45
Huang, H., Aladelokun, O. B., Ideta, T., Giardina, C. A., Ellis, L. M., & Rosenberg, D. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-40848-4 · Cited by 45
Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance
Atkins, R. J., Stylli, S. S., Kurganovs, N. J., Mangiola, S., Nowell, C. J., Ware, T. M. B., Corcoran, N. M., Brown, D. V., Kaye, A. H., Morokoff, A. P., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.12.010 · Cited by 44
Stein, R. G., Ebert, S., Schlahsa, L., Scholz, C. J., Braun, M., Hauck, P., Horn, E., Monoranu, C., Thiemann, V., Wustrow, M. P., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0387 · Cited by 44
Banerjee, A., Birts, C. N., Darley, M., Parker, R., Mirnezami, A. H., West, J. J., Cutress, R., Beers, S. A., Rose-Zerilli, M. J. J., & Blaydes, J. P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy174 · Cited by 44
miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway
Ran, R.-Z., Chen, J., Cui, L., Lin, X., Fan, M., Cong, Z., Zhang, H., Tan, W., Zhang, G., & Zhang, Y.-J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.007 · Cited by 43
Quayle, L. A., Ottewell, P. D., & Holen, I. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9946-2 · Cited by 42
Wang, P., Wan, W., Xiong, S., Wang, J., Zou, D., Lan, C., Yu, S., Liao, B., Feng, H., & Wu, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-06086-2 · Cited by 41
Kipp, A. P., Deubel, S., Arnér, E. S. J., & Johansson, K. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.013 · Cited by 39
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells
Zhou, H., Yu, C., Kong, L., Xu, X., Yan, J., Li, Y., An, T., Gong, L., Gong, Y., Zhu, H., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0674-5 · Cited by 39
Chen, Z., Li, W., Qiu, F., Huang, Q., Jiang, Z., Ye, J., Cheng, P., Low, C., Guo, Y., Yi, X., et al. (2018) · Theranostics · doi:10.7150/thno.24284 · Cited by 38
Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
Gold, A., Eini, L., Nissim‐Rafinia, M., Viner‐Breuer, R., Ezer, S., Erez, K., Aqaqe, N., Hanania, R., Milyavsky, M., Meshorer, E., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0654-9 · Cited by 37
Fouse, S. D., Nakamura, J. L., James, C. D., Chang, S. M., & Costello, J. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not223 · Cited by 36
The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
Fonseca, N. A., Cruz, A. F., Moura, V., Simões, S., & Moreira, J. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.016 · Cited by 36
Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics
Boesch, M., Zeimet, A. G., Rumpold, H. F., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0054 · Cited by 34
da Hora, C. C., Pinkham, K., de Carvalho, L. A., Zinter, M., Tabet, E. I., Nakano, I., Tannous, B. A., & Badr, C. E. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0155-9 · Cited by 32
Overcoming Chemoresistance in Cancer Stem Cells with the Help of microRNAs in Colorectal Cancer
Fesler, A. T., Guo, S., Liu, H., Wu, N., & Ju, J. (2017) · Epigenomics · doi:10.2217/epi-2017-0041 · Cited by 30
DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse
Filipponi, D., Emelyanov, A., Müller, J., Molina, C., Nichols, J., & Bulavin, D. V. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.002 · Cited by 30
You, Y., Bi, F., Jiang, Y., Xu, Y., An, Y., Li, D., & Yang, Q. F. (2019) · Cancer Medicine · doi:10.1002/cam4.1975 · Cited by 28
Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance
Chen, Y., Luo, L., Goto, S., Urata, Y., Guo, C., Doi, H., Kitazato, K., & Li, T. (2016) · Oncotarget · doi:10.18632/oncotarget.8972 · Cited by 26
Rapid phenotyping of cancer stem cells using multichannel nanosensor arrays
Geng, Y., Goel, H. L., Le, N. D. B., Yoshii, T., Mout, R., Tonga, G. Y., Amante, J. J., Mercurio, A. M., & Rotello, V. M. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.009 · Cited by 25
Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors
Andey, T. A., Bora-Singhal, N., Chellappan, S., & Singh, M. S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.02.007 · Cited by 25
Buenrostro, D., Kwakwa, K. A., Putnam, N. E., Merkel, A. R., Johnson, J., Cassat, J. E., & Sterling, J. A. R. (2018) · Bone · doi:10.1016/j.bone.2018.05.008 · Cited by 22
Li, Y., Gong, D., Zhang, L., Li, H., Zhang, S., Zhang, J., Li, K., Zheng, Q., Zhao, G., Zhang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1144-2 · Cited by 22
Reinforcing targeted therapeutics with phenotypic stability factors
Yaswen, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985071 · Cited by 18
Feng, Y., Guo, X., Huang, X., Wu, M., Li, X., Wu, S., & Luo, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9348 · Cited by 17
Lee, I., Wu, Y., & Hung, W.-S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14006 · Cited by 15
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells
Dingwall, S., Lee, J. B., Guezguez, B., Fiebig‐Comyn, A., McNicol, J. D., Boreham, D. R., Collins, T. J., & Bhatia, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4165 · Cited by 12
Tannous, B. A., & Badr, C. E. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1505-5 · Cited by 12
Ishida, R., Koyanagi‐Aoi, M., Oshima, N., Kakeji, Y., & Aoi, T. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0071 · Cited by 11
Mousa, S. A., Sudha, T., Dyskin, E., Dier, U., Gallati, C., Hanko, C., Chittur, S. V., & Rebbaa, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.018 · Cited by 7
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00522-z · Cited by 569
Engineered exosomes from different sources for cancer-targeted therapy
Zhang, M., Hu, S., Liu, L., Dang, P., Liu, Y., Sun, Z., Qiao, B., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01382-y · Cited by 468
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Metadata
- Authors
- Najafi, M., Mortezaee, K., & Majidpoor, J.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 234
- Pages
- 116781
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2967686606
- Cited by
- 466
- References
- 162
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.